PATENT CLAIM ANALYSIS

Application Number: 15771722
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["424", "174100"]

Abstract:
The present disclosure relates to a method for treating biliary tract cancer in a subject by inhibiting tenascin W by administering to said subject a therapeutically effective amount of a modulator of said tenascin, for example a specific antibody or a siRNA. The present disclosure also encompasses methods of diagnosing cancer by measuring levels of tenascin-W, as well as method of targeted therapy using anti-tenascin-W antibodies conjugated to therapeutic agents.

Claim (Index 15):
The method of  claim 14  wherein the therapeutic agent is selected from the group consisting of cytokines, toxins, small molecules, isotopes.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.5102
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10509009', '15329223', '13207705', '12303343', '15169460']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.705211872930596
- 35 USC 102 Novelty (BERT): 0.5108402948190466
- Combined Prediction Score: 0.6857747151194411
- Mean Citation Score: 189.274156
- Max Citation Score: 215.1969
- Similarity Product: 129.77257796596885

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test